LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

Home・Akcijų sąrašas・Pulse Biosciences Inc

Pulse Biosciences Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

14.26 0.07

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

13.9

Max

14.35

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-217K -19M
Pardavimai	86K 86K
Pelnas, tenkantis vienai akcijai	-0.29
Pelno marža	-22,540.698
Darbuotojai	75
EBITDA	-228K -19M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+54.6% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-179M 958M
Ankstesnė atidarymo kaina	14.19
Ankstesnė uždarymo kaina	14.26

Naujienos nuotaikos

By Acuity

34%

66%

100 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

16.59 / 17.17 Palaikymas ir pasipriešinimas

Pulse Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-17 23:50; UTC

Karštos akcijos

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

2025-12-17 23:20; UTC

Uždarbis

Correction to Micron Logs Sales Jump Article

2025-12-17 23:07; UTC

Uždarbis

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

2025-12-17 21:37; UTC

Uždarbis

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

2025-12-17 23:53; UTC

Rinkos pokalbiai

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

2025-12-17 23:43; UTC

Rinkos pokalbiai

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

2025-12-17 23:06; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

2025-12-17 23:05; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

2025-12-17 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

2025-12-17 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

2025-12-17 23:02; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

2025-12-17 22:59; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

2025-12-17 22:57; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

2025-12-17 22:56; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

2025-12-17 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

2025-12-17 22:49; UTC

Rinkos pokalbiai

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

2025-12-17 21:58; UTC

Uždarbis

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

2025-12-17 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-12-17 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-17 21:46; UTC

Uždarbis

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

2025-12-17 21:20; UTC

Uždarbis

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

2025-12-17 21:10; UTC

Uždarbis

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

2025-12-17 21:05; UTC

Uždarbis

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

2025-12-17 21:04; UTC

Uždarbis

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

2025-12-17 21:04; UTC

Uždarbis

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

2025-12-17 21:03; UTC

Uždarbis

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

2025-12-17 21:03; UTC

Uždarbis

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

2025-12-17 21:03; UTC

Uždarbis

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

2025-12-17 21:02; UTC

Uždarbis

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

2025-12-17 21:01; UTC

Uždarbis

Micron Technology 1Q Rev $13.64B >MU

Akcijų palyginimas

Kainos pokytis

Pulse Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

54.6% į viršų

12 mėnesių prognozė

Vidutinis 22 USD 54.6%

Aukščiausias 22 USD

Žemiausias 22 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pulse Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Pulse Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

16.59 / 17.17Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Rinkos nuotaikos

By Acuity

100 / 374 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.